VBI Vaccines

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

Related Content

Regulatory

VBI Vaccines receives positive EMA Scientific Advice regarding Sci-B-Vac Phase III clinical Study

VBI Vaccines Inc. has received positive Scientific Advice for its Sci-B-Vac vaccine in Europe
Research & Development

VBI Vaccines appoints Dr Francisco Diaz-Mitoma as Chief Medical Officer

He will oversee clinical development initiatives at the firm
Research & Development

VBI Vaccines applies its eVLP platform to development of Zika vaccine

The eVLP platform enables the development of vaccines that mimic the structure of viruses found in nature
Research & Development

Sanofi Pasteur to use VBI technology to develop more stable vaccine candidate

French company has the option to acquire certain worldwide rights to LPV technology
Subscribe now